Skip to content
RDL Network logo
Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY — Stephen B. Hanauer (2024) | RDL Network